Dyne Therapeutics Stock Target Price and Analyst Consensus
| DYN Stock | USD 15.55 0.00 0.00% |
The current analyst and expert consensus on Dyne Therapeutics is Strong Buy with 6 buy recommendations. The current projected Dyne Therapeutics target price consensus is 39.13, with 14 analyst opinions. Dyne Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Dyne Therapeutics target price to derive its highest and lowest estimates based on target price estimated volatility of 4.113. Check out Macroaxis Advice on Dyne Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.
Lowest Forecast 35.6 | Highest Forecast 43.43 | Target Price 39.13 |
It's important to approach Dyne Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Dyne Therapeutics price targets
Dyne Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Dyne Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Dyne Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Dyne Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Dyne Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Dyne Therapeutics is a key component of Dyne Therapeutics valuation and have some predictive power on the future returns of a Dyne Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dyne Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 90 shares | |
 | SRI Sustainable Growth Invested over 90 shares | |
 | ESG Investing Sold few shares | |
 | Social Domain Invested over 90 shares | |
Check out Macroaxis Advice on Dyne Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.